B Birkedal‐Hansen
- Cancer Research top 0.5%
- Oncology top 2%
- Molecular Biology top 10%
- Hematology top 1%
- Immunology and Allergy top 1%
- Co-authors
- Henning Birkedal‐HansenL. Jack WindsorMalena BoddenJeffrey A. EnglerWilliam G. I. MooreArthur A. DeCarloJ. Guy LyonsGregory J. Harber
- Topics
- Protease and Inhibitor Mechanisms (19 papers)Peptidase Inhibition and Analysis (12 papers)Enzyme Production and Characterization (6 papers)
- Partner nations
- United StatesAustraliaDenmark
In The Last Decade
B Birkedal‐Hansen
22 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 2.2k
- Oncology 1.2k
- Molecular Biology 816
- Hematology 752
- Immunology and Allergy 433
Countries citing papers authored by B Birkedal‐Hansen
This map shows the geographic impact of B Birkedal‐Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Birkedal‐Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Birkedal‐Hansen more than expected).
Fields of papers citing papers by B Birkedal‐Hansen
This network shows the impact of papers produced by B Birkedal‐Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Birkedal‐Hansen. The network helps show where B Birkedal‐Hansen may publish in the future.
Co-authorship network of co-authors of B Birkedal‐Hansen
This figure shows the co-authorship network connecting the top 25 collaborators of B Birkedal‐Hansen. A scholar is included among the top collaborators of B Birkedal‐Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Birkedal‐Hansen. B Birkedal‐Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 32 | |
| 2 | 15 | |
| 3 | 40 | |
| 4 | 46 | |
| 5 | 35 | |
| 6 | 107 | |
| 7 | 8 | |
| 8 | 9 | |
| 9 | 56 | |
| 10 | 107 | |
| 11 | 79 | |
| 12 | Matrix Metalloproteinases: A Reviewbreakdown → | 2585 |
| 13 | A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts. | 2 |
| 14 | Strategies for production of inhibitory monoclonal antibodies against matrix-degrading proteinases. | 1 |
| 15 | Mr 95,000 metalloproteinase produced by rat mammary epithelial cells. | 1 |
| 16 | Degradation of collagen fibrils by live cells: role of expression and activation of procollagenase. | 10 |
| 17 | 78 | |
| 18 | 74 | |
| 19 | 15 | |
| 20 | 86 |
About B Birkedal‐Hansen
B Birkedal‐Hansen is a scholar working on Cancer Research, Pharmacy and Biotechnology, having authored 22 papers that have together received 3.4k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (19 papers), Peptidase Inhibition and Analysis (12 papers) and Enzyme Production and Characterization (6 papers). The work is most often cited by research in Cancer Research (2.2k citations), Periodontics (386 citations) and Immunology and Allergy (433 citations). B Birkedal‐Hansen has collaborated with scholars based in United States, Australia and Denmark. Frequent co-authors include Henning Birkedal‐Hansen, L. Jack Windsor, Malena Bodden, Jeffrey A. Engler, William G. I. Moore, Arthur A. DeCarlo, J. Guy Lyons, Gregory J. Harber, John M. Whitelock and Robert E. Taylor. Their work appears in journals such as Journal of Biological Chemistry, Blood and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.